The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
P3BEP (ANZUP 1302): An international randomised phase 3 trial of accelerated versus standard BEP chemotherapy for adult and paediatric male and female patients with intermediate and poor-risk metastatic germ cell tumours (GCTs).
 
Peter S. Grimison
Research Funding - Boston Biomedical (Inst); Gilead Sciences (Inst); Halozyme (Inst); MSD (Inst); Pfizer (Inst); Specialised Therapeutics (Inst); Tigermed (Inst); Tigermed (Inst); Tilray (Inst)
Travel, Accommodations, Expenses - IPSEN
 
Nicola Jane Lawrence
No Relationships to Disclose
 
Martin R. Stockler
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bionomics (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Medivation (Inst); Pfizer (Inst); Sanofi (Inst)
 
Andrew James Martin
No Relationships to Disclose
 
Sonia Yip
No Relationships to Disclose
 
Nicole Wong
No Relationships to Disclose
 
Annie Yeung
No Relationships to Disclose
 
Michael Friedlander
Honoraria - AstraZeneca; Pfizer
Consulting or Advisory Role - AstraZeneca; Pfizer
 
Danish Mazhar
No Relationships to Disclose
 
Farzana Pashankar
Stock and Other Ownership Interests - Alexion Pharmaceuticals
 
David I. Quinn
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; EMD Serono; Exelixis; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Novartis; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Dendreon; EMD Serono; Exelixis; Genentech/Roche; Merck Serono; Merck Sharp & Dohme; Novartis; Peloton Therapeutics; Pfizer; Piramal Life Science; Sanofi
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
 
Rick Walker
No Relationships to Disclose
 
Mark Winstanley
No Relationships to Disclose
 
Fritha J. Hanning
No Relationships to Disclose
 
Andrew James Weickhardt
Consulting or Advisory Role - Eisai; Merck; Novartis
Research Funding - Novartis; Pfizer
Travel, Accommodations, Expenses - Astellas Medivation; Novartis; Sanofi
 
Amanda Gwendolyn Stevanovic
No Relationships to Disclose
 
Ian D. Davis
Research Funding - Astellas Pharma (Inst); Exelixis (Inst)
Patents, Royalties, Other Intellectual Property - International Patent Application No: PCT /US2004/032147 (NY-ESO-1) through Ludwig Institute for Cancer Research.
 
Guy C. Toner
Consulting or Advisory Role - Amgen (Inst); Bayer (Inst)
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Medivation (Inst); Medivation (Inst)